This syndrome affects IR through adipokine dysregulation, where altered adipokine secretion (e.g., elevated leptin and reduced adiponectin) fosters systemic inflammation and leptin resistance, leading to hyperglycemia. Here, LEP is linked to Hyperglycemia.